Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
1402
mi
from
Bellevue, WA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
1402
mi
from
Bellevue, WA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
The Polyclinic
1410
mi
from
Seattle, WA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
The Polyclinic
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Dean Foundation For Health Research & Education
572
mi
from
Middleton, WI
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Dean Foundation For Health Research & Education
572
mi
from
Middleton, WI
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Axiom Research
1101
mi
from
Apple Valley, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Axiom Research
1101
mi
from
Apple Valley, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
QUEST Research Institute
830
mi
from
Farmington Hills, MI
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
QUEST Research Institute
830
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Jordan River Family Medicine
779
mi
from
South Jordan, UT
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Jordan River Family Medicine
779
mi
from
South Jordan, UT
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
1140
mi
from
San Diego, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
1140
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
523
mi
from
Albuquerque, NM
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
523
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Sunrise Clinical Research, Inc.
1309
mi
from
Hollywood, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Sunrise Clinical Research, Inc.
1309
mi
from
Hollywood, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Catalina Research Institute, LLC
1137
mi
from
Montclair, CA
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Catalina Research Institute, LLC
1137
mi
from
Montclair, CA
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Sensible Healthcare
1132
mi
from
Ocoee, FL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Sensible Healthcare
1132
mi
from
Ocoee, FL
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
5602
mi
from
Ciudad Autonoma de Buenos Aires,
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
5602
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated:  12/31/1969
Christie Clinic
539
mi
from
Champaign, IL
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
Status: Enrolling
Updated: 12/31/1969
Christie Clinic
539
mi
from
Champaign, IL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
21st Century Neurology
852
mi
from
Phoenix, AZ
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
21st Century Neurology
852
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Arizona Research Center
848
mi
from
Phoenix, AZ
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Arizona Research Center
848
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Encino
1181
mi
from
Encino, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Encino
1181
mi
from
Encino, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Fullerton Neurology and Headache Center
1153
mi
from
Fullerton, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Fullerton Neurology and Headache Center
1153
mi
from
Fullerton, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Los Alamitos
1164
mi
from
Los Alamitos, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Los Alamitos
1164
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Newport Beach
1161
mi
from
Newport Beach, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Newport Beach
1161
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Desert Valley Research
1076
mi
from
Rancho Mirage, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Desert Valley Research
1076
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Anderson Clinical Research
1109
mi
from
Redlands, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
1109
mi
from
Redlands, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
1140
mi
from
San Diego, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
1140
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Optimus Medical Group
1181
mi
from
San Francisco, CA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Optimus Medical Group
1181
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Colorado Neurological Institute
408
mi
from
Englewood, CO
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Colorado Neurological Institute
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Advanced Neurosciences Research, LLC
429
mi
from
Fort Collins, CO
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Advanced Neurosciences Research, LLC
429
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Associated Neurologists of Southern Connecticut, PC
1328
mi
from
Fairfield, CT
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Associated Neurologists of Southern Connecticut, PC
1328
mi
from
Fairfield, CT
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Avail Clinical Research
1123
mi
from
DeLand, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Avail Clinical Research
1123
mi
from
DeLand, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
1061
mi
from
Jacksonville, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
1061
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
1078
mi
from
Ocala, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
1141
mi
from
Orlando, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
1141
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Compass Research
1144
mi
from
Oviedo, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Compass Research
1144
mi
from
Oviedo, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute at Palm Beach Neurology
1280
mi
from
West Palm Beach, FL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute at Palm Beach Neurology
1280
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Trials
1046
mi
from
Boise, ID
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Trials
1046
mi
from
Boise, ID
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Robbins Headache Clinic
607
mi
from
Riverwoods, IL
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Robbins Headache Clinic
607
mi
from
Riverwoods, IL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Midwest Institute for Clinical Research
643
mi
from
Indianapolis, IN
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Midwest Institute for Clinical Research
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Phoenix Medical Research
192
mi
from
Prairie Village, KA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Phoenix Medical Research
192
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
32
mi
from
Wichita, KA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
32
mi
from
Wichita, KA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Pharmasite Research
1142
mi
from
Baltimore, MD
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Pharmasite Research
1142
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
1444
mi
from
Boston, MA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Michigan Head Pain & Neurological Institute
807
mi
from
Ann Arbor, MI
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Michigan Head Pain & Neurological Institute
807
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
551
mi
from
Minneapolis, MN
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
551
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Clinvest
250
mi
from
Springfield, MO
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Clinvest
250
mi
from
Springfield, MO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
523
mi
from
Albuquerque, NM
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
523
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Dent Neurological Institute
1061
mi
from
Amherst, NY
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Dent Neurological Institute
1061
mi
from
Amherst, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Island Neuro Associates,PC
1315
mi
from
Plainview, NY
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Island Neuro Associates,PC
1315
mi
from
Plainview, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati College of Medicine
724
mi
from
Cincinnati, OH
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati College of Medicine
724
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Consultant
154
mi
from
Tulsa, OK
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Consultant
154
mi
from
Tulsa, OK
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
1227
mi
from
Willow Grove, PA
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
1227
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of South Carolina
1054
mi
from
Charleston, SC
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Chronic Migraine - the REGAIN Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of South Carolina
1054
mi
from
Charleston, SC
Click here to add this to my saved trials